NEW DELHI: Dr Reddy’s Laboratories is likely to post 10-16 per cent rise in profit for the December quarter on an 8-10 per cent jump in sales. Edelweiss Securities expects profit to rise 16.6 per cent year-on-year to Rs 565 crore compared with Rs 485.20 crore. The brokerage sees revenue rising 10.2 per cent to Rs 4,243 crore from Rs 3,850 crore. The brokerage expects the drug maker to report 11.1 per cent rise in profit at Rs 538 crore. It sees sales rising 8.3 per cent to Rs 4,099 crore and Ebitda 26.8 per cent to Rs 1,020 crore.

Source: Economic Times January 26, 2020 09:56 UTC